DICOM PS3.17 2020a - Explanatory Information |
Page 533 |
FFF.2.1.6.3 Encoding Details
This section provides detailed recommendations of the key Attributes to address this particular scenario.
Table FFF.2.1-46. Enhanced X-Ray Angiographic Image IOD Modules
IE |
Module |
PS3.3 Reference |
Usage |
Image |
Enhanced Contrast/Bolus |
C.7.6.4b |
Specifies the characteristics of the contrast |
|
|
|
agent(s) administered. |
Table FFF.2.1-47. Enhanced XA Image Functional Group Macros
Functional Group Macro |
PS3.3 Reference |
Usage |
Contrast/Bolus Usage |
C.7.6.16.2.12 |
Specifiesthepresenceofcontrastintheframe(s). |
FFF.2.1.6.3.1 Enhanced Contrast/bolus Module Recommendations
The usage of this module is recommended to specify the type and characteristics of the contrast agent administered.
FFF.2.1.6.3.2 Contrast/bolus Usage Macro Recommendations
The usage of this macro is recommended to specify the characteristics of the contrast per-frame.
Table FFF.2.1-48. Contrast/Bolus Usage Macro Recommendations
Attribute Name |
Tag |
Comment |
Contrast/Bolus Usage Sequence |
(0018,9341) |
One item per contrast agent used in this frame. |
>Contrast/Bolus Agent Number |
(0018,9337) |
Contains the internal number of the agent administered as specified |
|
|
in the Enhanced Contrast/Bolus Module. |
>Contrast/Bolus Agent Administered |
(0018,9342) |
The value "YES" indicates that the contrast may be visible on the |
|
|
frame, but not necessarily if the frame is acquired before the contrast |
|
|
reaches the imaged region. |
>Contrast/Bolus Agent Detected |
(0018,9343) |
The value "YES" is used if the contrast is visible on that particular |
|
|
frame. |
Note that it is not expected to be YES if Contrast/Bolus Agent
Administered (0018,9342) equals NO.
FFF.2.1.6.4 Example
In this example, the user starts the X-Ray acquisition at 4 frames per second at 3:35pm. After one second the user starts the injection of 45 milliliters of contrast media Iodipamide (350 mg/ml Cholographin (Bracco) ) at a flow rate of 15 ml/sec during three seconds, in intra-arterial route. When the injection of contrast agent is finished, the user continues the X-Ray acquisition for two seconds until wash out of the contrast agent.
There could be two ways to determine the presence of contrast agent on the frames:
•The injector is connected to the X-Ray acquisition system, the presence of contrast agent is determined based on the injector start/stop signals and a preconfigured delay to allow the contrast to reach the artery of interest, or.
•The X-Ray system processes the images in real time and detects the presence or absence of contrast agent on the images.
In this example, the image acquired contains 25 frames: From frames 5 to 17, the contrast is being injected. From frames 8 to 23, the contrast is visible on the pixel data.
The figure below shows the Attributes of this example in a graphical representation of the multi-frame acquisition.